Clinical Features of COVID-19 Patients in Xiaogan City

Abstract

On February 6, 2020, Xiaogan City became the second most seriously affected city with coronavirus disease 2019 (COVID-19), outside Wuhan district, Hubei Province, China. The objectives are to study the clinical features of COVID-19 patients and assess the relationship between the severity of COVID-19, age, and C-reactive protein (CRP) levels. The retrospective data of 134 COVID-19 patients hospitalized in 3 hospitals of Xiaogan City, between February 1 and March 1, 2020, was collected. This study documented COVID-19 patients. Clinical data in terms of body temperature, history of travel, and direct contact with COVID-19 patients, and incubation period was collected. Out of the 134 patients, only 5 required intensive care. Moreover, 2 patients succumbed during this period. The median age of patients was 45 (33-56) years. The most common symptoms at the onset of disease were fever (66.4%), cough (33, 6%), and sore throat (14.7%). Amongst the medicines used, antiviral agents (92.3%) followed by the traditional Chinese medicine (89.5%) were most commonly used. In both the crude and adjusted (I to III) models, odds ratio and its 95% confidence interval for both age and CRP levels were > 1. Moreover, the smooth curve fitting graph reflected that the severity of COVID-19 was positively correlated with both age and CRP levels (all P value < 0.05). The signs and symptoms of COVID-19 patients were fairly moderate. The health care professionals treating the COVID-19 patients should be aware of the increased likelihood of progression to severe COVID-19 in elderly patients and those with high CRP levels.

Use of Traditional, Complementary and Integrative Medicine During the COVID-19 Pandemic: A Systematic Review and Meta-Analysis

“…One study was a survey that included patient data from two regions, Hong Kong and mainland China, separately, so we analyzed the data separately ( 71 ). Twenty-two studies were conducted in China ( 27 , 31 – 34 , 37 , 39 , 40 , 44 , 47 , 55 , 62 – 65 , 67 , 69 – 73 , 75 – 77 ), six in Saudi Arabia ( 18 , 21 – 23 , 25 , 26 ), five in India ( 10 , 41 , 46 , 60 , 61 ), three in the United States ( 35 , 42 , 45 ) and three in Turkey ( 38 , 49 , 66 ), and these were the most frequent countries included in this review. Among the population-based survey studies, thirty-one were conducted through online surveys only ( 17 , 18 , 20 , 22 , 23 , 25 , 26 , 28 – 31 , 35 , 42 , 43 , 45 , 48 – 54 , 57 – 62 , 66 , 68 , 74 ), one was an in-person interview ( 56 ), three were telephone interviews ( 10 , 21 , 38 ), and two were both in-person and online surveys ( 19 , 36 ).…”

“…Among the population-based survey studies, thirty-one were conducted through online surveys only ( 17 , 18 , 20 , 22 , 23 , 25 , 26 , 28 – 31 , 35 , 42 , 43 , 45 , 48 – 54 , 57 – 62 , 66 , 68 , 74 ), one was an in-person interview ( 56 ), three were telephone interviews ( 10 , 21 , 38 ), and two were both in-person and online surveys ( 19 , 36 ). Among the included studies, usage status of the interventions, including TCM ( n = 22) ( 27 , 32 – 34 , 37 , 39 , 40 , 44 , 47 , 55 , 63 – 65 , 67 , 69 – 73 , 75 – 77 ), functional food (supplements) or herbs ( n = 20) ( 17 – 24 , 29 , 36 , 38 , 43 , 49 – 52 , 57 – 59 ), mind-body practice or spiritual practice ( n = 9) ( 28 , 35 , 42 , 45 , 48 , 54 , 60 , 61 , 74 ), Ayurveda ( n = 2) ( 10 , 41 ), homeopathy ( n = 1) ( ...…”

“…Most of the data for surveys or patient chart reviews were collected during 2020. In approximately half of the studies, TCIM interventions were used for prophylactic purposes ( n = 28) ( 17 – 20 , 22 , 23 , 25 , 26 , 28 , 31 , 35 , 36 , 38 , 41 , 42 , 45 , 48 – 54 , 59 , 61 , 62 , 66 , 74 ), and the other half were used for therapeutic purposes ( n = 27) ( 21 , 24 , 27 , 32 – 34 , 37 , 39 , 40 , 44 , 46 , 47 , 55 , 58 , 63 – 65 , 67 , 69 – 73 , 75 – 77 ) ( Table 1 ).…”